New Strategies for the Treatment of Atrial Fibrillation
Open Access
- 15 September 2021
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (9) , 926
Abstract
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in the clinical practice. It significantly contributes to the morbidity and mortality of the elderly population. Over the past 25–30 years intense effort in basic research has advanced the understanding of the relationship between the pathophysiology of AF and atrial remodelling. Nowadays it is clear that the various forms of atrial remodelling (electrical, contractile and structural) play crucial role in initiating and maintaining the persistent and permanent types of AF. Unlike in ventricular fibrillation, in AF rapid ectopic firing originating from pulmonary veins and re-entry mechanism may induce and maintain (due to atrial remodelling) this complex cardiac arrhythmia. The present review presents and discusses in detail the latest knowledge on the role of remodelling in AF. Special attention is paid to novel concepts and pharmacological targets presumably relevant to the drug treatment of atrial fibrillation.Keywords
Funding Information
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (NKFIH K-119992, K- 135464, GINOP-2.3.2-15-2016-00006 and GINOP-2.3.2.-15-2016-00040, 2020-4.1.1-TKP2020 funding scheme)
- Emberi Eroforrások Minisztériuma (20391-3/2018/FEKUSTRAT and EFOP-3.6.2-16-2017-00006)
This publication has 192 references indexed in Scilit:
- The effect of the PQ1 anti-breast cancer agent on normal tissuesAnti-Cancer Drugs, 2012
- Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA studyEP Europace, 2011
- Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atriaHeart Rhythm, 2010
- Extracellular matrix remodeling in atrial fibrosis: Mechanisms and implications in atrial fibrillationJournal of Molecular and Cellular Cardiology, 2010
- Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillationJournal of Electrocardiology, 2009
- Connexin43 phosphorylation: structural changes and biological effectsBiochemical Journal, 2009
- Slow delayed rectifier K+ current block by HMR 1556 increases dispersion of repolarization and promotes Torsades de Pointes in rabbit ventriclesBritish Journal of Pharmacology, 2008
- Pathology‐specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillationBritish Journal of Pharmacology, 2008
- Genetics of atrial fibrillation: Rare mutations, common polymorphisms, and clinical relevanceHeart Rhythm, 2008
- Genetics of Atrial FibrillationMedical Clinics of North America, 2008